Research ArticleNEUROPHARMACOLOGY
Anandamide Is Able to Inhibit Trigeminal Neurons Using an in Vivo Model of Trigeminovascular-Mediated Nociception
S. Akerman, H. Kaube and P. J. Goadsby
Journal of Pharmacology and Experimental Therapeutics April 2004, 309 (1) 56-63; DOI: https://doi.org/10.1124/jpet.103.059808